Edistride Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Dapagliflozin

Indications/Uses

Improve glycemic control as an adjunct to diet & exercise in adults w/ type 2 DM as monotherapy or in combination w/ other medicinal products. Reduce risk of CV death & hospitalization for heart failure in adults w/ heart failure (NYHA class II-IV). Adjunct to standard therapy to reduce the risk of sustained eGFR decline, ESRD & CV death in adults w/ CKD at risk of progression.

Dosage/Direction for Use

Recommended dose: 10 mg once daily at any time of the day.

Administration

May be taken with or without food. Take regardless of meals.

Contraindications

Hypersensitivity.

MIMS Class

Antidiabetic Agents

ATC Classification

A10BK01 - dapagliflozin ; Belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors. Used in the treatment of diabetes.

Regulatory Classification

POM

Presentation/Packing

Form

Edistride FC tab 10 mg

Packing/Price

1's

Edistride

Manufacturer:

AstraZeneca